| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |